What is Synjardy, and what is it used for?
Synjardy is a prescription medicine used to treat type 2 diabetes. It combines two active ingredients in one tablet: empagliflozin and metformin. The combination helps lower blood sugar by working through two different mechanisms.[1]
What are the main ingredients in Synjardy?
Synjardy contains:
- Empagliflozin (an SGLT2 inhibitor)
- Metformin (a biguanide that helps reduce glucose production and improve insulin sensitivity)[1]
What’s the difference between Synjardy and Synjardy XR?
Synjardy XR is the extended-release version of Synjardy. XR formulations are designed to release medicine more slowly over time than immediate-release versions, which can affect dosing schedules and how patients tolerate the medicine.[1]
How is Synjardy typically taken?
Dosing depends on the specific product (Synjardy vs Synjardy XR) and the patient’s current diabetes regimen, kidney function, and tolerance. Your clinician sets the dose, and it is usually taken with meals for GI tolerability (for the metformin component). Follow the directions on your prescription label.[1]
Does Synjardy have generic or brand alternatives?
Whether a cheaper alternative exists depends on the specific formulation and patent status at the time you’re asking. DrugPatentWatch.com tracks patent and exclusivity information for medicines and can help you check what might be available in your timeframe.[2]
Who makes Synjardy?
DrugPatentWatch.com lists manufacturer and patent-related information for medicines like Synjardy, which can help you identify the current branded product holder(s).[2]
Sources
- https://www.drugs.com/synjardy.html
- https://www.drugpatentwatch.com/